QResearch Produces New Fracture Risk Score

A simple new score which can predict the risk of patients suffering fractured bones due to osteoporosis has been developed using the QResearch database. The algorithm, QFractureScores, can be used by clinicians and patients and calculates an individual's percentage risk of an osteoporotic fracture over the next ten years, allowing early intervention to take place.

The tool, which is available as open source software at www.qfracture.org, was developed using data from QResearch - the world's largest medical database for ethical research.

A not-for-profit partnership between the University of Nottingham and leading healthcare IT provider EMIS, QResearch collects anonymised patient data from EMIS GP practices across the UK in order to detect patterns of disease and other conditions.

The anonymised health records of more than two million men and women, registered at 357 GP practices in England and Wales, were analysed over a 15 year period in order to produce the QFractureScores algorithm.

Julia Hippisley-Cox, Professor of Clinical Epidemiology and Clinical Practice at the University of Nottingham, who is a co-director of QResearch and director of ClinRisk Ltd (which developed the open source software) said: "Osteoporotic fracture is a major cause of illness and a considerable burden to the health service.

"The new algorithm is able to identify patients who are at high risk of fracture who may benefit from early interventions. It is suitable for both clinical settings and for self assessment, making it an extremely valuable and easy-to-use tool."

Dr David Stables, co-founder of EMIS and a co-founder of QResearch, said: "This is a great example of how we can improve patient care and save the health service money by using the vast store of accurate, anonymous data contained within QResearch.

"Making the new algorithm available as open source software stands to widen its use, so that even more people can benefit."

Users of the new algorithm enter details including age, sex, weight, height and illnesses, in order to determine the risk of a fracture.

The QResearch database has already been used to produce the QRISK and QRISK2 formulas, which identify patients most at risk of developing cardiovascular disease, and the QDScore, an algorithm which can identify people at high risk of diabetes.

More than 600 EMIS practices make regular contributions to the QResearch database, representing around eight million patients.

Related news articles:

  • QRESEARCH is a non-profit making venture run by the University of Nottingham in collaboration with EMIS. More than 600 EMIS practices, representing around eight million patients, regularly contribute to the database. The system anonymises and uploads practices' clinical data to the central database. Then, to protect patient confidentiality, the data are further anonymised and the figures are totalled to produce data that are suitable for research. (www.qresearch.org).
  • EMIS is the UK's leading supplier of IT systems to GPs, providing the software that holds medical records for 39 million NHS patients nationwide. Around 56 per cent of GPs in the UK currently use EMIS software. www.emis-online.com
  • ClinRisk Ltd produces software to help ensure the safe and reliable implementation of clinical risk scores into clinical practice and their wide availability.

Most Popular Now

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Record Year with More than 800 Exhibit…

9 - 11 April 2024, Berlin, Germany. DMEA 2024 kicks off today, focusing on the key issues in the digital transformation of the healthcare system. From now until 11 April over...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...